Fish oil replacement prevents, while docosahexaenoic acid‐derived protectin DX mitigates end‐stage‐renal‐disease in atherosclerotic diabetic mice

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States

(2019) Rajiv Saran et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes

(2019) Ian H. de Boer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of body mass index and diastolic function in metabolically healthy obese with preserved ejection fraction

(2018) Zach Rozenbaum et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The angiotensin II type 2 receptors protect renal tubule mitochondria in early stages of diabetes mellitus

(2018) Tamara Micakovic et al.   KIDNEY INTERNATIONAL

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETES CARE

NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury

(2017) Guangbi Li et al.   JOURNAL OF LIPID RESEARCH

Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk

(2017) Marcela A. Casanova et al.   Journal of the American Society of Hypertension

How Dangerous Is Hyperkalemia?

(2017) John R. Montford et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy

(2017) Zubair Ilyas et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

(2017) Tarec K. Elajami et al.   Journal of the American Heart Association

Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals

(2017) Ligang Xia et al.   Scientific Reports

Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease

(2016) Marcello Tonelli et al.   CIRCULATION

Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury

(2016) Irina A. Leaf et al.   JOURNAL OF CLINICAL INVESTIGATION

Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

(2016) Bruce M Robinson et al.   LANCET

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

(2016) Linda A. Gallo et al.   Scientific Reports

Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome

(2015) Charles N. Serhan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Diabetic kidney disease

(2015) Merlin C. Thomas et al.   Nature Reviews Disease Primers

Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials

(2014) P. E. Miller et al.   AMERICAN JOURNAL OF HYPERTENSION

Early Development of Calcific Aortic Valve Disease and Left Ventricular Hypertrophy in a Mouse Model of Combined Dyslipidemia and Type 2 Diabetes Mellitus

(2014) Khai Le Quang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis

(2014) Phillip J White et al.   NATURE MEDICINE

Mechanisms of muscle wasting in chronic kidney disease

(2014) Xiaonan H. Wang et al.   Nature Reviews Nephrology

Lipid Mediators in the Resolution of Inflammation

(2014) Charles N. Serhan et al.   Cold Spring Harbor Perspectives in Biology

Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes

(2013) Nicolas Drapeau et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation

(2013) A. Neuhofer et al.   DIABETES

Associations between structural and functional changes to the kidney in diabetic humans and mice

(2013) David W. Powell et al.   LIFE SCIENCES

Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+ channels

(2013) T. Hoshi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Omega-3 fatty acids and blood pressure

(2012) Jorge Cabo et al.   BRITISH JOURNAL OF NUTRITION

Recent Findings on the Effects of Marine-Derived n-3 Polyunsaturated Fatty Acids on Urinary Albumin Excretion and Renal Function

(2012) C. Christine Lee et al.   Current Atherosclerosis Reports

Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis

(2012) Cheng-Ying Chiu et al.   INFLAMMATION RESEARCH

Omega–3 Fatty Acids Ameliorate Proteinuria but Not Renal Function in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials

(2012) Hsin-Hsu Chou et al.   NEPHRON CLINICAL PRACTICE

β-Cell-specific pyruvate dehydrogenase deficiency impairs glucose-stimulated insulin secretion

(2010) Malathi Srinivasan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Transgenic Restoration of Long-Chain n-3 Fatty Acids in Insulin Target Tissues Improves Resolution Capacity and Alleviates Obesity-Linked Inflammation and Insulin Resistance in High-Fat-Fed Mice

(2010) P. J. White et al.   DIABETES

Dietary Intake of Eicosapentaenoic and Docosahexaenoic Acid and Diabetic Nephropathy: Cohort Analysis of the Diabetes Control and Complications Trial

(2010) C. C. Lee et al.   DIABETES CARE

The global burden of diabetes and its complications: an emerging pandemic

(2010) Dieren Susan van et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy

(2010) John P. Middleton et al.   KIDNEY INTERNATIONAL

Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis

(2010) M. A. Losi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The effect of n–3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials

(2009) Edgar R Miller et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation

(2009) H. Kolb et al.   DIABETOLOGIA

Acute Changes in Dietary  -3 and  -6 Polyunsaturated Fatty Acids Have a Pronounced Impact on Survival following Ischemic Renal Injury and Formation of Renoprotective Docosahexaenoic Acid-Derived Protectin D1

(2009) I. R. Hassan et al.   JOURNAL OF IMMUNOLOGY

Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells

(2008) Takaharu Ichimura et al.   JOURNAL OF CLINICAL INVESTIGATION